Status:

RECRUITING

NeuroN-QI: An Intervention to Promote Preterm Infants' Neurodevelopment

Lead Sponsor:

St. Justine's Hospital

Conditions:

Neurodevelopmental Disorders

Eligibility:

All Genders

24-34 years

Phase:

NA

Brief Summary

NeuroN-QI aims to evaluate the effects of an intervention consisting of periods of: 1) parents/preterm infants skin-to-skin contact and auditory stimulation by the parents's voice and 2) calm without ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for preterm infants:
  • born between 24 and 33 6/7 weeks GA;
  • ready for SSC
  • Inclusion criteria for mothers and fathers:
  • agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant;
  • mothers express breast milk for their preterm infants
  • For twin births (twin pregnancies), fathers will also be invited to participate in the study, so that both infants can participate in the study.
  • Exclusion criteria for preterm infants:
  • congenital anomalies or genetic disorders
  • intraventricular hemorrhage \> grade II
  • are small for GA defined as birth weight \<10th percentile
  • on postnatal day 19 (maximum days targeted for study start)
  • are still receiving analgesics, sedatives, paralyzing agents
  • are under mechanical ventilation
  • Exclusion criteria mothers and fathers:
  • are aged \<18 years;
  • have a physical condition that does not allow the SSC
  • abuse illicit substances or alcohol that could influence stress, anxiety and parent- child interactions
  • feed their preterm infant exclusively with commercial infant formula
  • mothers had a breast surgery that could influence their breast milk production
  • do not speak, read or write in French or in English

Exclusion

    Key Trial Info

    Start Date :

    November 23 2023

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    October 1 2027

    Estimated Enrollment :

    124 Patients enrolled

    Trial Details

    Trial ID

    NCT06087744

    Start Date

    November 23 2023

    End Date

    October 1 2027

    Last Update

    April 19 2024

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    CHU Sainte-Justine

    Montreal, Quebec, Canada, H3T 1C5

    2

    CUSM

    Montreal, Quebec, Canada, H4A 3J1